Clinoptilolite zeolite,
does it really help with Heavy-metal adsorption and systemic detoxification?
research showsA randomized trial in 42 participants found that purified clinoptilolite G-PUR taken together with a trace lead dose reduced blood exposure to the lead isotope by about 86% to 90%, supporting a signal for intestinal lead adsorption. This was a single-dose pharmacokinetic result for newly ingested lead and does not establish removal of metals already stored in tissues or broad systemic detoxification. Only one component of the compound claim has limited support, resulting in an overall C.
ads claimProduct descriptions may extend intestinal ion exchange and lead co-adsorption to removal of heavy metals, mycotoxins, pesticides, and radioactive materials from cells, blood, liver, or brain. The most directly supported human claim is that one purified product reduced absorption of lead ingested at the same time.
Useful facts when choosing a product
- Zeolite names a mineral group, and the purified clinoptilolite used in clinical trials cannot be treated as interchangeable with every zeolite powder.
- The G-PUR trial was a single-dose pharmacokinetic study using 2 to 4 g together with lead exposure.
- Mineral source, purification, particle size, trace-metal contamination, and ion-exchange properties can vary by product.
- Adsorption may also affect absorption of oral medicines or nutrients, and product-specific interaction and spacing data are needed.
What the research actually shows
The 2021 trial by Samekova and colleagues randomized 42 healthy adults to G-PUR 2 g, 4 g, or placebo taken with 2.5 micrograms of 204Pb. Blood 204Pb AUC fell from 86.4 percent-hours with placebo to 11.9 and 8.5 percent-hours, corresponding to an 86% to 90% reduction in absorption, while total blood lead did not change during the study. Glock Health sponsored the single-center trial of its branded product. The 2009 study by Flowers and colleagues gave a commercial activated clinoptilolite product to 22 healthy men and reported only urinary heavy-metal concentrations; it did not establish total excretion or a reduction in body burden. A 2025 trial in 80 patients with lead poisoning described the study product only as a 'zeolite tablet,' without confirming clinoptilolite content or mineral composition, so the result cannot be attributed directly to clinoptilolite; improvement in clinical symptoms or organ injury was also not established.
Why this is classified as C (42)
Reduced absorption of simultaneously ingested lead receives C rather than a question mark or D because a strong surrogate signal appeared in one manufacturer-sponsored RCT. However, removal of preexisting body metals depends on urinary-concentration data that do not establish total excretion or lower body burden, the 2025 zeolite trial did not confirm clinoptilolite content or mineral composition, and systemic toxins and clinical outcomes are unsupported, resulting in 42 points in the lower C range.
Counterpoint. The human signal that the exact G-PUR formulation reduces intestinal uptake of newly ingested lead is clear. This judgment separates that result from removal of stored metals or broad systemic detoxification.
Rejudgment record. Reassessment (cross-check reflected) — A manufacturer-sponsored single RCT was positive for reduced uptake of lead ingested with purified clinoptilolite, but this was a single-dose pharmacokinetic surrogate and there is no evidence for removal of preexisting body metals, broad systemic detoxification, or clinical outcomes
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Intestinal adsorption of co-ingested lead | C | Single-dose G-PUR pharmacokinetic trial in 42 participants. |
| Removal of accumulated heavy metals | D | The Flowers study reported urinary concentrations only and did not establish total excretion or reduced body burden. |
| Broad systemic detoxification | ? | No clinoptilolite human trial assessing defined systemic toxins or clinical outcomes was identified. |
Cross-check — Codex and Claude
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Samekova K et al. 2021 | Randomized double-blind placebo-controlled parallel trial | 42 | Sponsored by Glock Health, Science and Research GmbH with company employees as coauthors | Blood and urine 204Pb Cmax and AUC | Co-administration of G-PUR 2 or 4 g reduced 204Pb uptake by 86% to 90%; total blood lead did not change. | Key |
| Flowers JL et al. 2009 | Uncontrolled before-and-after clinical study | 30 | Authors affiliated with product and wellness companies | Urinary heavy-metal concentrations and serum electrolytes | Reported increased urinary heavy-metal concentrations from baseline, but lacked placebo and adequate assessment of total excretion or body burden. | Low |
| Teimouri S et al. 2025 | Randomized assessor-blinded controlled trial | 2 | Academic institutions and a public hospital | Serum lead and hematologic, liver, and kidney laboratory measures | The product was described only as a 'zeolite tablet,' leaving clinoptilolite content and mineral composition unconfirmed; clinical outcomes were not assessed. | Indirect |
| Kraljević Pavelić S et al. 2022 | Integrated analysis of blood metals and minerals from three clinical trials | Research grants from Panaceo International GmbH | Blood minerals and metals and longer-term safety | Provided safety data for one PMA product but was not a systemic-detox efficacy trial and explicitly cautioned against generalization to other products. | Safety |
Receipt — 4 References
Of 4 cited sources, 1 had limited original-page access (blocked or summary-only) and were verified via index/summary, marked partial; the rest were verified at the original page. As of 2026-07-11.
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-11 · Corrections: none
Cite this verdict
[Chamgap] Clinoptilolite zeolite × Heavy-metal adsorption and systemic detoxification — Evidence Grade C·42. 4 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/general/clinoptilolite-heavy-metals-detox/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.